Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Altered focal adhesion regulation correlates with cardiomyopathy in mice expressing constitutively active rac1
Mark A. Sussman, … , Erik Schaefer, Karen Yager
Mark A. Sussman, … , Erik Schaefer, Karen Yager
Published April 1, 2000
Citation Information: J Clin Invest. 2000;105(7):875-886. https://doi.org/10.1172/JCI8497.
View: Text | PDF
Article

Altered focal adhesion regulation correlates with cardiomyopathy in mice expressing constitutively active rac1

  • Text
  • PDF
Abstract

The ras family of small GTP-binding proteins exerts powerful effects upon cell structure and function. One member of this family, rac, induces actin cytoskeletal reorganization in nonmuscle cells and hypertrophic changes in cultured cardiomyocytes. To examine the effect of rac1 activation upon cardiac structure and function, transgenic mice were created that express constitutively activated rac1 specifically in the myocardium. Transgenic rac1 protein was expressed at levels comparable to endogenous rac levels, with activation of the rac1 signaling pathway resulting in two distinct cardiomyopathic phenotypes: a lethal dilated phenotype associated with neonatal activation of the transgene and a transient cardiac hypertrophy seen among juvenile mice that resolved with age. Neither phenotype showed myofibril disarray and hypertrophic hearts were hypercontractilein working heart analyses. The rac1 target p21-activated kinase translocated from a cytosolic to a cytoskeletal distribution, suggesting that rac1 activation was inducing focal adhesion reorganization. Corroborating results showed altered localizations of src in dilated cardiomyopathy and paxillin in both cardiomyopathic phenotypes. This study, the first examination of rac1-mediated cardiac effects in vivo, demonstrates that dilation and hypertrophy can share a common molecular origin and presents evidence that both timing and concurrent signaling from multiple pathways can influence cardiac remodeling.

Authors

Mark A. Sussman, Sara Welch, Angela Walker, Raisa Klevitsky, Timothy E. Hewett, Robert L. Price, Erik Schaefer, Karen Yager

×

Figure 2

Options: View larger image (or click on image) Download as PowerPoint
Gross morphology of dilated and hypertrophic racET hearts. (Top) Bisecte...
Gross morphology of dilated and hypertrophic racET hearts. (Top) Bisected racET hearts ranging from 7 to 15 days of age (bottom row) compared with typical ntg control hearts shown at 9, 12, and 15 days for comparison (top row). Ntg control hearts show a progressive increase in heart size consistent with rapid postnatal growth in this period. In comparison, racET hearts are enlarged with severely dilated chambers and thin ventricular walls. Atria are also increased in size relative to ntg controls, although to a lesser degree than ventricles. (Middle) Postnatal thyroid hormone supplementation correlates with development of racET cardiomyopathy. Hearts from ntg control mice developed normally without apparent morphologic effects from supplementation (left, shown at 2 weeks of age). In contrast, hearts from supplemented racET mice all developed lethal dilated cardiomyopathy within 1.5 weeks after birth. (Bottom) Bisected hearts ranging from 3 weeks to 6 months of age for ntg controls (top row) and racET mice (bottom row). Concentric hypertrophy is evident in the 3-week-old racET ventricles, but hypertrophic characteristics diminish as the mice age. In contrast, atria in racET mice show severe enlargement by 2 months after birth and continued deterioration as the mice age.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts